Form
Powder
Appearance
White powder
Source
Semi-synthetic
Water Content (Karl Fisher)
≤8.5%
pH
9.5 - 11.5
Optical Rotation
+97° to +105°
Assay
(On Dried Basis): ≥900µg/mg
Residue On Ignition
≤1.0%
Amikacin hydrate is broad spectrum aminoglycoside antibiotic derived from its counterpart kanamycin A.
TOKU-E offers three forms of amikacin: amikacin hydrate (A002), amikacin sulfate (1:2) (A003), and amikacin sulfate (1:1.8) (A070). All forms have similar potencies and are freely soluble in aqueous solution (50 mg/mL).
Sabaeifard et al. used amikacin hydrate from TOKU-E to study its cytotoxicity when used in combination with PLGA nanoparticles. Read more here: "Amikacin loaded PLGA nanoparticles against Pseudomonas aeruginosa."
37517-28-5
C22H43N5O13 •H2O
585.60 (anhydrous basis)
Similar to other aminoglycosides, amikacin binds to the 30S ribosomal subunit resulting in an inability to read mRNA ultimately producing a faulty or nonexistent protein.
2-8°C
2941.90.5000
Species susceptible to amikacin include gram negative bacteria such as Pseudomonas aeruginosa and several key enteric species. In addition, certain non-gram negative species including Mycobacterium tuberculosis have also demonstrated susceptibility to amikacin.
Powder
White powder
Semi-synthetic
≤8.5%
9.5 - 11.5
+97° to +105°
(On Dried Basis): ≥900µg/mg
≤1.0%